One-time infusion using CRISPR may permanently lower LDL cholesterol, reducing the risk of heart attack, stroke.
New study shows low-cost strategy is effective against growing misinformation around childbirth, resistance to evidence-based care.
Neurosurgeon is first in Oregon to implant devices that send small electrical pulses to stimulate healing, anti-inflammatory effect.
Researchers at Oregon Health & Science University’s Oregon Rural Practice-based Research Network and their partners at the University of Washington School of Medicine’s WWAMI region Practice and ...
Melinda Davis, Ph.D., M.C.R., director of the Oregon Rural Practice Research Network and professor of family medicine in the OHSU School of Medicine, alongside researchers at the UNC Lineberger ...
Oregon Health & Science University is Oregon's only academic health center and distinguished nationally as a research university dedicated solely to advancing health sciences. OHSU focuses on ...
OHSU’s media relations team is available from 8:30 a.m. to 5 p.m. weekdays. Interview requests are welcome. All inquiries involving OHSU faculty and staff should be initiated through the media ...
Una infusión puntual con CRISPR puede reducir permanentemente el colesterol LDL, disminuyendo el riesgo de infarto o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results